\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\:\\ temperature\\ 38\\.5\\,\\ heart\\ rate\\ 137\\,\\ respiratory\\ rate\\ 24\\,\\ blood\\ pressure\\ 101\\/69\\,\\ o2\\ sat\\ 97\\%\\ on\\ room\\ air\\.\ \(0\)\
\-\ gen\\:\\ nad\\,\\ alert\\,\\ awake\\,\\ and\\ smiling\\ playing\\ video\\ games\\.\ \(0\)\
\-\ pulm\\:\\ absent\\ breath\\ sounds\\ on\\ right\\ middle\\ and\\ right\\ lower\\ lobes\\.\\ \\ no\\ retractions\\.\ \(0\)\
\-\ exam\\ otherwise\\ unremarkable\ \(2\)\
\-\ lab\\:\\ wbc\\ 21\\.4\ \(0\)\
\-\ patient\\ was\\ started\\ on\\ 03\\-100a\\ cog\\ soft\\ tissue\\ sarcoma\\ protocol\\ with\\ 6\\ cycles\\ of\\ vac\\.\\ \\ patient\\ underwent\\ lobectomy\\ midway\\ through\\ chemo\\ treatments\\ and\\ following\\ chemo\\ received\\ post\\-op\\ radiation\\ therapy\\.\ \(0\)\
\-\ large\\ \\ irregular\\ \\ density\\ \\ in\\ \\ the\\ \\ region\\ \\ of\\ \\ the\\ \\ right\\ \\ middle\\ \\ lobe\\ \\ which\\ \\ measured\\ \\ approximately\\ \\ 10\\ \\ cm\\ \\ in\\ \\ its\\ \\ greatest\\ \\ diameter\\ with\\ pleural\\ effusion\\ at\\ time\\ of\\ presentation\\.\\ \\ this\\ would\\ be\\ consistent\\ with\\ type\\ iii\\ ppb\\.\\ \\ subsequent\\ imaging\\ following\\ chemotherapy\\ showed\\ a\\ good\\ response\\ to\\ therapy\\ with\\ little\\ tumor\\ remaining\\ 4\\ months\\ into\\ treatment\\.\ \(0\)\
\-\ pleuropulmonary\\ blastoma\ \(1\)\
\-\ \\â\\€\\¢\\ empyema\\ with\\ necrosis\ \(0\)\
\-\ \\â\\€\\¢\\ ewing\\'s\\ sarcoma\ \(0\)\
\-\ \\â\\€\\¢\\ askin\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ neuroblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ rhabdomyosarcoma\ \(2\)\
\-\ this\\ is\\ the\\ case\\ of\\ a\\ 5\\-year\\-old\\ male\\ who\\ presented\\ to\\ ed\\ with\\ complaints\\ of\\ respiratoy\\ distress\\ and\\ fever\\ for\\ the\\ past\\ week\\.\\ \\ patient\\ had\\ presented\\ to\\ primary\\ care\\ physician\\ the\\ prior\\ week\\ for\\ cough\\ and\\ fever\\ with\\ suspician\\ for\\ right\\ sided\\ pneumonia\\ and\\ was\\ given\\ zithromax\\.\\ \\ the\\ patient\\ finished\\ this\\ course\\ two\\ days\\ prior\\ to\\ presentation\\ in\\ ed\\ with\\ symptoms\\ having\\ failed\\ to\\ improve\\.\\ \\ pmh\\ is\\ significant\\ for\\ eczema\\ and\\ asthma\\ treated\\ with\\ albuterol\\.\\ \\ psh\\,\\ meds\\,\\ all\\,\\ fmh\\,\\ soch\\,\\ and\\ ros\\ are\\ all\\ non\\-contributory\\ other\\ than\\ mentioned\\ above\\.\ \(0\)\
\-\ patient\\ has\\ been\\ followed\\ hematology\\-oncology\\ extensively\\ and\\ continues\\ to\\ do\\ well\\ at\\ 2\\.5\\ years\\ after\\ diagnosis\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ chemo\\:\\ 0\\.04473930582458302\ \(0\)\
\-\ 101\\/69\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ 21\\.4\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ 03\\-100a\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ vac\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ ppb\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ respiratoy\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ suspician\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ soch\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ hematology\\-oncology\\:\\ 0\\.031150241780800347\ \(0\)\
\-\ 38\\.5\\:\\ 0\\.02870095845726697\ \(0\)\
\-\ games\\:\\ 0\\.02870095845726697\ \(0\)\
\-\ midway\\:\\ 0\\.02870095845726697\ \(0\)\
\-\ 5\\-year\\-old\\:\\ 0\\.02870095845726697\ \(0\)\
\-\ zithromax\\:\\ 0\\.02870095845726697\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.027685765929255972\ \(0\)\
\-\ smiling\\:\\ 0\\.02726821955935826\ \(0\)\
\-\ cog\\:\\ 0\\.02726821955935826\ \(0\)\
\-\ pleuropulmonary\\:\\ 0\\.02726821955935826\ \(0\)\
\-\ fmh\\:\\ 0\\.02726821955935826\ \(0\)\
\-\ sarcoma\\:\\ 0\\.026889633426644823\ \(0\)\
\-\ blastoma\\:\\ 0\\.026251675133733596\ \(0\)\
\-\ finished\\:\\ 0\\.026251675133733596\ \(0\)\
\-\ ed\\:\\ 0\\.02552305114409684\ \(0\)\
\-\ askin\\:\\ 0\\.02546318201954911\ \(0\)\
\-\ eczema\\:\\ 0\\.024818936235824887\ \(0\)\
\-\ extensively\\:\\ 0\\.02380239181020022\ \(0\)\
\-\ rate\\:\\ 0\\.023538667777214438\ \(0\)\
\-\ 137\\:\\ 0\\.02236965291229151\ \(0\)\
\-\ albuterol\\:\\ 0\\.02236965291229151\ \(0\)\
\-\ middle\\:\\ 0\\.022085929114080832\ \(0\)\
\-\ cycles\\:\\ 0\\.02182495086343194\ \(0\)\
\-\ psh\\:\\ 0\\.021353108486666845\ \(0\)\
\-\ 97\\:\\ 0\\.02113888720816354\ \(0\)\
\-\ presentation\\:\\ 0\\.020801417911597755\ \(0\)\
\-\ lobectomy\\:\\ 0\\.020564615372482355\ \(0\)\
\-\ week\\:\\ 0\\.02050894288571186\ \(0\)\
\-\ fever\\:\\ 0\\.02043295142439552\ \(0\)\
\-\ retractions\\:\\ 0\\.02039221196552323\ \(0\)\
\-\ ros\\:\\ 0\\.020227830284834564\ \(0\)\
\-\ pulm\\:\\ 0\\.02007075691885989\ \(0\)\
\-\ awake\\:\\ 0\\.019920369588758133\ \(0\)\
\-\ meds\\:\\ 0\\.01858717442571408\ \(0\)\
\-\ ewing\\:\\ 0\\.018487630690849428\ \(0\)\
\-\ empyema\\:\\ 0\\.01839081452764054\ \(0\)\
\-\ mentioned\\:\\ 0\\.018028079000926466\ \(0\)\
\-\ video\\:\\ 0\\.017942928641989857\ \(0\)\
\-\ post\\-op\\:\\ 0\\.01769913757666494\ \(0\)\
\-\ treatments\\:\\ 0\\.017471086265224763\ \(0\)\
\-\ o2\\:\\ 0\\.017326838934764496\ \(0\)\
\-\ sat\\:\\ 0\\.01718824984235007\ \(0\)\
\-\ following\\:\\ 0\\.01713977213357702\ \(0\)\
\-\ all\\:\\ 0\\.017080731374072726\ \(0\)\
\-\ temperature\\:\\ 0\\.01705489179294072\ \(0\)\
\-\ rhabdomyosarcoma\\:\\ 0\\.016990053847116705\ \(0\)\
\-\ failed\\:\\ 0\\.01686384154110229\ \(0\)\
\-\ nad\\:\\ 0\\.016741982261698863\ \(0\)\
\-\ greatest\\:\\ 0\\.016682593151040277\ \(0\)\
\-\ asthma\\:\\ 0\\.016682593151040277\ \(0\)\
\-\ gen\\:\\ 0\\.016624185723650837\ \(0\)\
\-\ presented\\:\\ 0\\.016461891413585932\ \(0\)\
\-\ measured\\:\\ 0\\.016399756728165585\ \(0\)\
\-\ little\\:\\ 0\\.016399756728165585\ \(0\)\
\-\ 2\\.5\\:\\ 0\\.016345808063392482\ \(0\)\
\-\ protocol\\:\\ 0\\.01624032056109679\ \(0\)\
\-\ therapy\\:\\ 0\\.016145871351523768\ \(0\)\
\-\ playing\\:\\ 0\\.016087768717050116\ \(0\)\
\-\ improve\\:\\ 0\\.016087768717050116\ \(0\)\
\-\ \\:\\:\\ 0\\.015975615773719646\ \(0\)\
\-\ continues\\:\\ 0\\.015755510944441366\ \(0\)\
\-\ remaining\\:\\ 0\\.015710496719079422\ \(0\)\
\-\ prior\\:\\ 0\\.015506097330052038\ \(0\)\
\-\ patient\\:\\ 0\\.015134133055059859\ \(0\)\
\-\ response\\:\\ 0\\.01513398915481711\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.015096196613768532\ \(0\)\
\-\ alert\\:\\ 0\\.015058804001293136\ \(0\)\
\-\ pmh\\:\\ 0\\.015021802941691385\ \(0\)\
\-\ lab\\:\\ 0\\.014773107546773365\ \(0\)\
\-\ vital\\:\\ 0\\.014445691184643665\ \(0\)\
\-\ physician\\:\\ 0\\.0142333098275069\ \(0\)\
\-\ iii\\:\\ 0\\.014174902400117461\ \(0\)\
\-\ tumor\\:\\ 0\\.014079380223397959\ \(0\)\
\-\ received\\:\\ 0\\.01403297292405621\ \(0\)\
\-\ having\\:\\ 0\\.013869856168709345\ \(0\)\
\-\ started\\:\\ 0\\.013468452713855262\ \(0\)\
\-\ lobes\\:\\ 0\\.01330622762090799\ \(0\)\
\-\ complaints\\:\\ 0\\.01310803162567462\ \(0\)\
\-\ do\\:\\ 0\\.01310803162567462\ \(0\)\
\-\ absent\\:\\ 0\\.013086680691201254\ \(0\)\
\-\ room\\:\\ 0\\.012981819319660205\ \(0\)\
\-\ good\\:\\ 0\\.012920364398416852\ \(0\)\
\-\ right\\:\\ 0\\.012743911082832744\ \(0\)\
\-\ distress\\:\\ 0\\.012722906948259761\ \(0\)\
\-\ diameter\\:\\ 0\\.012703754766389306\ \(0\)\
\-\ respiratory\\:\\ 0\\.012535901996124275\ \(0\)\
\-\ pneumonia\\:\\ 0\\.01248167736829862\ \(0\)\
\-\ sounds\\:\\ 0\\.012043627747372365\ \(0\)\
\-\ irregular\\:\\ 0\\.012043627747372365\ \(0\)\
\-\ necrosis\\:\\ 0\\.01191908379309083\ \(0\)\
\-\ pressure\\:\\ 0\\.011858420176050669\ \(0\)\
\-\ subsequent\\:\\ 0\\.011754702112402161\ \(0\)\
\-\ 24\\:\\ 0\\.011740130673589928\ \(0\)\
\-\ pleural\\:\\ 0\\.011725619076584086\ \(0\)\
\-\ cough\\:\\ 0\\.01156980522547022\ \(0\)\
\-\ \\,\\:\\ 0\\.011478872036068724\ \(0\)\
\-\ effusion\\:\\ 0\\.011474112792245235\ \(0\)\
\-\ its\\:\\ 0\\.011394104040479297\ \(0\)\
\-\ course\\:\\ 0\\.011394104040479297\ \(0\)\
\-\ breath\\:\\ 0\\.011290168050351055\ \(0\)\
\-\ sided\\:\\ 0\\.011164404993451045\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.011152071407091438\ \(0\)\
\-\ above\\:\\ 0\\.011066921048154828\ \(0\)\
\-\ wbc\\:\\ 0\\.011007331627476366\ \(0\)\
\-\ care\\:\\ 0\\.010891085325331281\ \(0\)\
\-\ otherwise\\:\\ 0\\.0108456368672309\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.010823129982829912\ \(0\)\
\-\ would\\:\\ 0\\.010745466001491483\ \(0\)\
\-\ signs\\:\\ 0\\.010626770084756376\ \(0\)\
\-\ heart\\:\\ 0\\.010491447522645844\ \(0\)\
\-\ underwent\\:\\ 0\\.010361116733138585\ \(0\)\
\-\ given\\:\\ 0\\.010351287606064814\ \(0\)\
\-\ for\\:\\ 0\\.010305415528518942\ \(0\)\
\-\ air\\:\\ 0\\.01021647571219776\ \(0\)\
\-\ this\\:\\ 0\\.010188733710043814\ \(0\)\
\-\ 10\\:\\ 0\\.01017888419910569\ \(0\)\
\-\ type\\:\\ 0\\.01017888419910569\ \(0\)\
\-\ followed\\:\\ 0\\.010123236294624634\ \(0\)\
\-\ unremarkable\\:\\ 0\\.00999670112608502\ \(0\)\
\-\ density\\:\\ 0\\.009935093133780774\ \(0\)\
\-\ radiation\\:\\ 0\\.00990901501612133\ \(0\)\
\-\ showed\\:\\ 0\\.009900364904324017\ \(0\)\
\-\ past\\:\\ 0\\.00959434442383899\ \(0\)\
\-\ approximately\\:\\ 0\\.009342112461327148\ \(0\)\
\-\ days\\:\\ 0\\.009254679491773773\ \(0\)\
\-\ to\\:\\ 0\\.009054447528826564\ \(0\)\
\-\ treated\\:\\ 0\\.009038342176974768\ \(0\)\
\-\ 6\\:\\ 0\\.009018092443020757\ \(0\)\
\-\ primary\\:\\ 0\\.008944820716945924\ \(0\)\
\-\ years\\:\\ 0\\.008866583523033506\ \(0\)\
\-\ two\\:\\ 0\\.008647813560480585\ \(0\)\
\-\ through\\:\\ 0\\.008575819853077274\ \(0\)\
\-\ region\\:\\ 0\\.008528626244661882\ \(0\)\
\-\ time\\:\\ 0\\.008528626244661882\ \(0\)\
\-\ 4\\:\\ 0\\.00841332828685175\ \(0\)\
\-\ months\\:\\ 0\\.008247142384063842\ \(0\)\
\-\ blood\\:\\ 0\\.00824173523854876\ \(0\)\
\-\ been\\:\\ 0\\.008214822930968167\ \(0\)\
\-\ at\\:\\ 0\\.008182071751460305\ \(0\)\
\-\ lobe\\:\\ 0\\.008124824550966551\ \(0\)\
\-\ significant\\:\\ 0\\.008119601240474287\ \(0\)\
\-\ cm\\:\\ 0\\.008098784868611257\ \(0\)\
\-\ than\\:\\ 0\\.007911833409605207\ \(0\)\
\-\ who\\:\\ 0\\.007872679890960077\ \(0\)\
\-\ on\\:\\ 0\\.00767375631482786\ \(0\)\
\-\ symptoms\\:\\ 0\\.007525291437802612\ \(0\)\
\-\ consistent\\:\\ 0\\.0074038808085908235\ \(0\)\
\-\ soft\\:\\ 0\\.007353098105984276\ \(0\)\
\-\ into\\:\\ 0\\.0071848988267127455\ \(0\)\
\-\ tissue\\:\\ 0\\.007156965330221179\ \(0\)\
\-\ imaging\\:\\ 0\\.007074465810797182\ \(0\)\
\-\ \\%\\:\\ 0\\.007043537220303914\ \(0\)\
\-\ was\\:\\ 0\\.006984293443206267\ \(0\)\
\-\ other\\:\\ 0\\.006959853528983917\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006933637211238233\ \(0\)\
\-\ well\\:\\ 0\\.006830674745472265\ \(0\)\
\-\ lower\\:\\ 0\\.00679103204722213\ \(0\)\
\-\ \\'s\\:\\ 0\\.00665740854546659\ \(0\)\
\-\ exam\\:\\ 0\\.006633335476853491\ \(0\)\
\-\ case\\:\\ 0\\.0066060227309797555\ \(0\)\
\-\ large\\:\\ 0\\.006602623434032084\ \(0\)\
\-\ had\\:\\ 0\\.006515370386009569\ \(0\)\
\-\ after\\:\\ 0\\.006247354072824037\ \(0\)\
\-\ treatment\\:\\ 0\\.006111720705303488\ \(0\)\
\-\ and\\:\\ 0\\.005724668026819668\ \(0\)\
\-\ has\\:\\ 0\\.0056703179169409115\ \(0\)\
\-\ which\\:\\ 0\\.005636553311811126\ \(0\)\
\-\ male\\:\\ 0\\.005460090239885064\ \(0\)\
\-\ be\\:\\ 0\\.004656384181427311\ \(0\)\
\-\ in\\:\\ 0\\.004467108446716483\ \(0\)\
\-\ are\\:\\ 0\\.004116162093744176\ \(0\)\
\-\ is\\:\\ 0\\.00397378641968004\ \(0\)\
\-\ with\\:\\ 0\\.0037209808650494965\ \(0\)\
\-\ no\\:\\ 0\\.003040438695066438\ \(0\)\
\-\ the\\:\\ 0\\.0029310802410662715\ \(0\)\
\-\ a\\:\\ 0\\.002802825454548419\ \(0\)\
\-\ of\\:\\ 0\\.0020583710388337177\ \(0\)\
\-\ \\.\\:\\ 0\\.0018816008532162338\ \(0\)\
